Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Therapy | 1 | 2020 | 144 | 0.700 |
Why?
|
| Skin Neoplasms | 5 | 2021 | 5319 | 0.660 |
Why?
|
| Hemangioma | 1 | 2019 | 736 | 0.480 |
Why?
|
| Pleural Neoplasms | 1 | 2018 | 618 | 0.460 |
Why?
|
| Mesothelioma | 1 | 2018 | 814 | 0.430 |
Why?
|
| Mutation, Missense | 1 | 2019 | 2515 | 0.360 |
Why?
|
| Melanoma | 4 | 2021 | 5246 | 0.350 |
Why?
|
| Uveal Neoplasms | 2 | 2021 | 305 | 0.320 |
Why?
|
| Neoplasms | 3 | 2021 | 20515 | 0.320 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3670 | 0.290 |
Why?
|
| Silk | 2 | 2015 | 88 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8560 | 0.250 |
Why?
|
| Cervix Uteri | 2 | 2018 | 578 | 0.220 |
Why?
|
| Tissue Embedding | 1 | 2019 | 46 | 0.180 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2019 | 133 | 0.170 |
Why?
|
| Sampling Studies | 1 | 2019 | 639 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2019 | 698 | 0.140 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 539 | 0.140 |
Why?
|
| Mutation | 3 | 2021 | 29253 | 0.140 |
Why?
|
| Calcium Channels | 1 | 2019 | 650 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 510 | 0.140 |
Why?
|
| Progesterone | 1 | 2018 | 734 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 12530 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2019 | 1899 | 0.120 |
Why?
|
| Oncogenes | 1 | 2019 | 1246 | 0.120 |
Why?
|
| Biological Products | 1 | 2021 | 839 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2022 | 1364 | 0.110 |
Why?
|
| Massachusetts | 2 | 2021 | 8742 | 0.100 |
Why?
|
| Electricity | 1 | 2011 | 175 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 162392 | 0.090 |
Why?
|
| Prognosis | 2 | 2020 | 28991 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 1937 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2975 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4192 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2018 | 1827 | 0.080 |
Why?
|
| Male | 7 | 2021 | 350143 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2983 | 0.080 |
Why?
|
| Motion | 1 | 2011 | 776 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2015 | 1179 | 0.080 |
Why?
|
| Sarcoma | 1 | 2018 | 1879 | 0.070 |
Why?
|
| Nanostructures | 1 | 2011 | 567 | 0.070 |
Why?
|
| Calcium | 1 | 2019 | 5793 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10600 | 0.070 |
Why?
|
| Boston | 1 | 2019 | 9374 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 13209 | 0.070 |
Why?
|
| Female | 8 | 2021 | 377052 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4560 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 1701 | 0.070 |
Why?
|
| Humans | 14 | 2022 | 715594 | 0.070 |
Why?
|
| Sex Factors | 1 | 2019 | 10660 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2213 | 0.060 |
Why?
|
| Prevalence | 1 | 2019 | 14877 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18772 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 8028 | 0.050 |
Why?
|
| Middle Aged | 3 | 2020 | 214639 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 8897 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11644 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20761 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5407 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 293 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23482 | 0.040 |
Why?
|
| Gelatin | 1 | 2018 | 214 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17399 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 72448 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 40040 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 402 | 0.040 |
Why?
|
| Adult | 2 | 2020 | 212237 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58293 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1903 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2014 | 143 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56140 | 0.030 |
Why?
|
| Cerclage, Cervical | 1 | 2014 | 38 | 0.030 |
Why?
|
| Sonication | 1 | 2014 | 79 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 926 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1255 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2787 | 0.030 |
Why?
|
| Apoptosis | 2 | 2019 | 9960 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13619 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6476 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 2985 | 0.030 |
Why?
|
| Sulfides | 1 | 2011 | 164 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 3070 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16726 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 2936 | 0.020 |
Why?
|
| Collagen | 1 | 2018 | 2664 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4263 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4303 | 0.020 |
Why?
|
| Copper | 1 | 2011 | 380 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2015 | 2218 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3800 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5387 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7944 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5338 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2015 | 1957 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 16559 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 6028 | 0.010 |
Why?
|
| Pyridines | 1 | 2015 | 2843 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16302 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19529 | 0.010 |
Why?
|
| Animals | 3 | 2019 | 169173 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19892 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 24794 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23705 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 27362 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 80270 | 0.010 |
Why?
|
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_